ArticleCurrent oncology (Toronto, Ont.)2020

Practical update for the use of bone-targeted agents in patients with bone metastases from metastatic breast cancer or castration-resistant prostate cancer.

D Southcott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.